Canada supplies 29.7% of U.S. imports of Antimalarial Medicaments in Measured Doses for Retail Sale, across 7 countries (year to date through August 2026).
HHI 1,980 of 10,000 · HHI above 1,800. The sum of each country’s squared percentage share; one country with everything scores 10,000.
7 countries supplying this product to the U.S.
| Rank# | Country | Value | Share | YoY | Duty |
|---|---|---|---|---|---|
| 1 | India | $184K | 90.1% | -18.4% | 0.0% |
| 2 | China | $16K | 7.6% | -- | 0.0% |
| 3 | Italy | $5K | 2.3% | -34.2% | 0.0% |
| 4 | Turkey | -- | 0.0% | +12541.4% | -- |
| 5 | Croatia | -- | 0.0% | -15.6% | -- |
| 6 | Switzerland | -- | 0.0% | -54.3% | -- |
| 7 | Canada | -- | 0.0% | +11.4% | -- |
Duty is the duty Census calculated on this month's imports for consumption from each country, as a share of their customs value. It applies the rates in force, additional duties such as Section 301, 232 and IEEPA included and claimed trade-agreement preferences netted out, so it is an observed rate rather than a statutory one. It is an estimate, not duty collected: antidumping and countervailing duties, fees and later refunds are not in it. YoY compares year-to-date value with the same months last year.